Teradoc health The actions fell into extended negotiation on Wednesday after the company reported a broader loss of what analysts expected and issued Disappointing quarterly guide.
This is how the company did, compared to the consensus estimates of the LSE analysts:
- Loss by action: 28 cents vs. 24 expected cents
- Revenue: $ 640.5 million compared to $ 639.6 million
Revenue in the Telesalud company decreased 3% in the fourth quarter of $ 660.5 million during the same period last year, according to a statement. The net loss of Teladoc was extended to $ 48.4 million, or 28 cents per share, for a loss of $ 28.9 million, or 17 cents per share, a year ago.
Teladoc is in the middle of a deep fall, with the price of its action in each of the last four years due to a strong competition in remote health, challenges in the Psychological HEALTH DIVISION besthelp and high operating costs.
When Teladoc acquired the Livongo digital health company in 2020, companies had a combined business value of $ 37 billion. The Celadoc market capitalization was around $ 1.9 billion from the closure of the market on Wednesday.
“As we wait in 2025, the execution will continue to be a priority as we advance the efforts to unlock growth opportunities and position the company for long -term success,” said the CEO of Teradoc, Chuck Divita, in the statement. “We will also continue focused on our cost structure, based on the significant improvements achieved in 2024 during the previous year.”
Teladoc reported adjusted profits of $ 74.8 million in its fourth quarter, a 35% decrease in a year ago. The adjusted profits for the company’s integrated service segment decreased 5% to $ 53.2 million, and Betterhelp saw a drop in adjusted profits by 63% to $ 21.7 million.
For the first quarter, Teradoc said he expects revenues of between $ 608 million and $ 629 million, while analysts waited $ 632.9 million. The company said that adjusted profits will be between $ 47 million and $ 59 million for the period.
Earl this month, Celadoc announced that it will acquire a preventive care company Catapult health in a cash agreement for $ 65 million. Teladoc said his perspective includes the anticipated contribution of the agreement, but not the effect of possible impediments or purchasing accounting. Teladoc said the acquisition should be closed at the end of the month.
Teladoc will organize its quarterly call with investors at 4:30 pm et.
– Bertha Coombs of CNBC contributed to this report.
